Ws. Edgemond et al., SYNTHESIS AND CHARACTERIZATION OF DIAZOMETHYLARACHIDONYL KETONE - AN IRREVERSIBLE INHIBITOR OF N-ARACHIDONYLETHANOLAMINE AMIDOHYDROLASE, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 184-190
N-Arachidonylethanolamine (AEA), a putative endogenous agonist of neur
onal (CB1) cannabinoid receptors, is a substrate for N-arachidonyletha
nolamine amidohydrolase (AEA amidohydrolase), a serine amidase present
in cell membranes. Following a strategy that has been used to develop
inhibitors that covalently bind to the active site of serine peptidas
es, diazomethyl arachidonyl ketone (DAK) was synthesized and its effec
ts on AEA amidohydrolase were determined. DAK inhibits the hydrolysis
of AEA by rat brain membranes with an IC50 value of 0.5 mu M. At low c
oncentrations, DAK reduces the V-max and increases the K-m of the enzy
me for its substrate AEA, which suggests that it is both a competitive
and noncompetitive inhibitor. At higher concentrations, DAK inhibitio
n is completely noncompetitive. DAK inhibition of membrane-associated
AEA amidohydrolase is irreversible because hydrolytic activity is not
restored with extensive washing or dialysis of the membranes. Furtherm
ore, DAK inhibition is not reversible by anion exchange chromatography
of the subsequently solubilized enzyme. In contrast, DAK inhibition o
f detergent-solubilized enzyme exhibits competitive kinetics and is re
versible upon ion exchange chromatography. Exposure of C6 glioma cells
to DAK results in concentration-related inhibition of AEA amidohydrol
ase activity in cellular membranes with an IC50 value of 0.3 mu M. In
summary, these studies demonstrate that DAK is an irreversible inhibit
or of AEA amidohydrolase in its native membrane and provides a useful
tool with which to study the role of AEA amidohydrolase in the termina
tion of action of AEA.